BACKGROUND: Monitoring the quality and availability of alcohol and other drug (AOD) services must be a central tenet of any health-related performance measurement system. The Washington Circle Group (WCG), which was convened by the Center for Substance Abuse Treatment Office of Managed Care in March 1998, has developed a core set of performance measures for AOD services for public- and private-sector health plans. It is also collaborating with a broad range of stakeholders to ensure widespread adoption of these performance measures by health plans, private employers, public payers, and accrediting organizations. CORE PERFORMANCE MEASURES: Four domains were identified, with specific measures developed for each domain: (1) prevention/education, (2) recognition, (3) treatment (including initiation of alcohol and other plan services, linkage of detoxification and AOD plan services, treatment engagement, and interventions for family members/significant others), and (4) maintenance of treatment effects. CONTINUING EFFORTS: Four measures that are based on administrative information from health plans and two measures that require a consumer survey of behavioral health care are undergoing extensive pilot testing. The WCG has reached out to a broad range of stakeholders in performance measurement and managed care to acquaint them with the measures and to promote their investigation and adoption. As results of pilot testing become available, these outreach efforts will continue. CONCLUSIONS: Performance measures for AOD services need to become an integral part of a comprehensive set of behavioral and physical health performance measures for managed care plans.
BACKGROUND: Monitoring the quality and availability of alcohol and other drug (AOD) services must be a central tenet of any health-related performance measurement system. The Washington Circle Group (WCG), which was convened by the Center for Substance Abuse Treatment Office of Managed Care in March 1998, has developed a core set of performance measures for AOD services for public- and private-sector health plans. It is also collaborating with a broad range of stakeholders to ensure widespread adoption of these performance measures by health plans, private employers, public payers, and accrediting organizations. CORE PERFORMANCE MEASURES: Four domains were identified, with specific measures developed for each domain: (1) prevention/education, (2) recognition, (3) treatment (including initiation of alcohol and other plan services, linkage of detoxification and AOD plan services, treatment engagement, and interventions for family members/significant others), and (4) maintenance of treatment effects. CONTINUING EFFORTS: Four measures that are based on administrative information from health plans and two measures that require a consumer survey of behavioral health care are undergoing extensive pilot testing. The WCG has reached out to a broad range of stakeholders in performance measurement and managed care to acquaint them with the measures and to promote their investigation and adoption. As results of pilot testing become available, these outreach efforts will continue. CONCLUSIONS: Performance measures for AOD services need to become an integral part of a comprehensive set of behavioral and physical health performance measures for managed care plans.
Authors: Jennifer P Wisdom; James H Ford Ii; Randy A Hayes; Eldon Edmundson; Kim Hoffman; Dennis McCarty Journal: J Behav Health Serv Res Date: 2006-10 Impact factor: 1.505
Authors: Kevin L Kraemer; Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Adam J Gordon; Jonathan Robbins; Susan Zickmund; Kendall Bryant; P Todd Korthuis Journal: J Subst Abuse Treat Date: 2019-05-07
Authors: Deborah W Garnick; Constance M Horgan; Margaret T Lee; Lee Panas; Grant A Ritter; Steve Davis; Tracy Leeper; Rebecca Moore; Mark Reynolds Journal: J Subst Abuse Treat Date: 2007-05-23
Authors: Fred A Mael; Patrick Gavan O'Shea; Mark Alan Smith; Andrea Seidner Burling; Kristin L Carman; Amie Haas; Kelly S Rogers Journal: J Behav Health Serv Res Date: 2010-01 Impact factor: 1.505
Authors: Bryan R Garner; Susan H Godley; Rodney R Funk; Michael L Dennis; Jane Ellen Smith; Mark D Godley Journal: J Subst Abuse Treat Date: 2008-08-20
Authors: Kimberly A Hepner; Susan M Paddock; Katherine E Watkins; Katherine J Hoggatt; Lisa V Rubenstein; Andy Bogart; Praise O Iyiewuare; Susan C Rosenbluth; Harold Alan Pincus Journal: J Gen Intern Med Date: 2018-11-27 Impact factor: 5.128